<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(9)</volume><submitter>Dai L</submitter><pubmed_abstract>SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The e</pubmed_abstract><journal>PloS one</journal><pagination>e0274823</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9488775</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas.</pubmed_title><pmcid>PMC9488775</pmcid><pubmed_authors>Dai L</pubmed_authors><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>Tong J</pubmed_authors><pubmed_authors>Lu C</pubmed_authors><pubmed_authors>Mugaanyi J</pubmed_authors><pubmed_authors>Cai X</pubmed_authors></additional><is_claimable>false</is_claimable><name>A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas.</name><description>SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The e</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-18T15:48:13.456Z</modification><creation>2024-11-09T18:20:40.645Z</creation></dates><accession>S-EPMC9488775</accession><cross_references><pubmed>36126083</pubmed><doi>10.1371/journal.pone.0274823</doi></cross_references></HashMap>